WARREN STACKS: Open Payments
NPI 1740203090 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 12 payments from 7 companies in 2025. Trend: 2023 $281 · 2024 $415 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| Dexcom, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Amgen Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: FARXIGA, JARDIANCE, Ozempic, Dexcom G6 Transmitter, LEQVIO, EVENITY, NEXLETOL.
Industry payments across NC — which companies pay providers there.
